E Fund Management’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Other funds holding SANA
FP
RCM
MG
E Fund Management's SANA Position: Q2 2026 in Review
E Fund Management reduced its Sana Biotechnology (SANA) stake by 38% in Q2 2026, selling an estimated $53.8K and leaving 27,740 shares worth $96.8K. The position accounts for ﹤0.01% of the portfolio, ranked #475.
E Fund Management first reported a position in SANA in Q1 2022 and has held it in 15 quarters since. The position peaked at $273K in Q2 2022. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.
- E Fund Management held 27,740 shares of Sana Biotechnology worth $96.8K as of Q2 2026.
- E Fund Management sold 16,706 Sana Biotechnology shares in Q2 2026, an estimated $53.8K.
- Sana Biotechnology made up ﹤0.01% of E Fund Management's portfolio in Q2 2026, its #475 holding.
- E Fund Management first reported a position in Sana Biotechnology in Q1 2022 and has held it in 15 quarters since.
- E Fund Management's Sana Biotechnology position peaked at $273K in Q2 2022.
- 212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.
Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.